Unresectable Gallbladder Carcinoma Recruiting Phase 1 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0046852 (Unresectable Gallbladder Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs